We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Thomas J. Arista
Thomas J. Arista
Products
PRODUCTS
Element Materials Technology Oakland-Concord
Thomas J. Arista
,
Jolanna A. Norton
, and
Jeffrey P. Raimondi
Price:
$117.00
View
Teva Parenteral Medicines, Inc.
Amir Alavi
,
Thomas J. Arista
,
Bryan A. Galvez
,
Santiago Gallardo Johnson
,
Sangeeta M. Khurana
, and
Walden H. Lee
Price:
$117.00
View
Zhuhai United Laboratories Co., Ltd.
Thomas J. Arista
Price:
$117.00
View
Intas Pharmaceuticals, Ltd.
Thomas J. Arista
and
Rita K. Kabaso
Price:
$117.00
View
Cipla Ltd.
Thomas J. Arista
,
June P. Page
, and
Rajiv R. Srivastava
Price:
$117.00
View
Reddy's Laboratories Ltd.
Thomas J. Arista
and
Bijoy Panicker
Price:
$117.00
View
Hospira Healthcare India Pvt.
Thomas J. Arista
and
Daniel J. Roberts
Price:
$117.00
View
Dr. Reddy's Laboratories, Ltd.
Thomas J. Arista
,
Michael R. Klapal
, and
Steven M. Weinman
Price:
$117.00
View
ZS Pharma, Inc.
Thomas J. Arista
and
Massoud Motamed
Price:
$117.00
View
Apotex Research Private, Ltd.
Thomas J. Arista
,
Peter E. Baker
, and
Parul M. Patel
Price:
$117.00
View
View All Products by Thomas J. Arista
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More